S. Grivennikov
Immunology · 2009–2019
A researcher in the Science corpus: 9 papers; trusts 22 researchers and is trusted by 11 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 188 citations into it; #860 of 2,160 by trust here, #279 by citations
- Oncology — 187 citations into it; #203 of 1,698 by trust here, #144 by citations
- Molecular Biology — 116 citations into it
- Cancer Research — 78 citations into it; #769 of 1,780 by trust here, #577 by citations
- Epidemiology — 26 citations into it; #1,349 of 2,148 by trust here, #1,155 by citations
Whom S. Grivennikov trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- M. Karin
- G. Dunn
- F. Balkwill
- Hua Yu
- A. Mantovani
- Robert Schreiber
- James E. Darnell
- D. Gabrilovich
- Lloyd J. Old
- Wan-Wan Lin
Who trusts S. Grivennikov overall
- M. Karin
- T. Hirano
- S. Shalapour
- K. Taniguchi
- F. Greten
- F. Balkwill
- N. Perkins
- M. Park
- Y. Ben‐Neriah
- Chunbai He
Papers from S. Grivennikov's perspective
Ordered by how strongly the researchers S. Grivennikov trusts endorse each paper. Same corpus, a different order for every researcher.
- Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells (Nature Medicine)
- IL-6 and STAT3 are required for survival of intestinal epithelial cells and development of colitis associated cancer (Cancer Cell)
- Cancer-related inflammation (Nature)
- Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells (Journal of Experimental Medicine)
- NF-κB functions as a tumour promoter in inflammation-associated cancer (Nature)
- The STATs of cancer — new molecular targets come of age (Nature Reviews. Cancer)
- Hallmarks of cancer: the next generation. (Cell)
- Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens (Nature Medicine)
- Smoldering and polarized inflammation in the initiation and promotion of malignant disease. (Cancer Cell)
- Inflammation and cancer (Nature)
Their papers
- Inflammation and Cancer: Triggers, Mechanisms and Consequences (2019) — 3,133 citations
- Fibroblast-recruited, tumor-infiltrating CD4+ T cells stimulate mammary cancer metastasis through RANKL-RANK signaling (2011) — 637 citations
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth (2012) — 1,264 citations
- Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. (2012) — 690 citations
- Inflammation and colon cancer. (2010) — 1,989 citations
- Immunity, Inflammation, and Cancer (2010) — 10,296 citations
- IL-6 and STAT3 are required for survival of intestinal epithelial cells and development of colitis associated cancer (2009) — 2,165 citations
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer (2009) — 1,169 citations
- Carcinoma Produced Factors Activate Myeloid Cells via TLR2 to Stimulate Metastasis (2009) — 1,048 citations